A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2

NCT04721535 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Termination of study due to sponsor's internal decision

Conditions

Covid19
SARS-COV-2 Infection

Interventions

DRUG: DWJ1248
DRUG: Placebo

Sponsor

Daewoong Pharmaceutical Co. LTD.